Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Metastasis From Malignant Tumor of Prostate”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableNot Yet RecruitingNCT06198387
What this trial is testing

Radiotherapy for Prostate and Oligo-metastatic Lesions in Patients With Low-burden Oligo-metastatic Prostate Cancer

Who this might be right for
Oligo-metastatic Prostate Carcinoma
Changhai Hospital 30
Testing effectiveness (Phase 2)Looking for participantsNCT07073794
What this trial is testing

Evaluating In Home Cancer Therapy Versus In Clinic Cancer Therapy in Black Men With Locally Advanced, Biochemically Recurrent and Metastatic Prostate Cancer

Who this might be right for
Biochemically Recurrent Prostate CarcinomaLocally Advanced Prostate CarcinomaMetastatic Prostate Carcinoma+2 more
Mayo Clinic 38
Testing effectiveness (Phase 2)WithdrawnNCT01153113
What this trial is testing

Human Telomerase Reverse Transcriptase Messenger RNA (hTERT mRNA) Transfected Dendritic Cell Vaccines

Who this might be right for
Metastatic Prostate Cancer
University of Florida
Testing effectiveness (Phase 2)Active Not RecruitingNCT04709276
What this trial is testing

Chemoimmunotherapy for the Treatment of Men With Neuroendocrine or Aggressive Variant Metastatic Prostate Cancer

Who this might be right for
Metastatic Prostate Neuroendocrine CarcinomaMetastatic Prostate Cancer
Andrew J. Armstrong, MD 41
Testing effectiveness (Phase 2)UnknownNCT04031378
What this trial is testing

Single Dose Radiotherapy (SDRT) With or Without Adjuvant Systemic Therapy for Oligometastatic Prostate Cancer

Who this might be right for
Metastatic Prostate CancerProstate Adenocarcinoma
Fundacao Champalimaud 100
Testing effectiveness (Phase 2)Active Not RecruitingNCT03173924
What this trial is testing

18F-DCFPyL PSMA- Versus 18F-NaF-PET Imaging for Detection of Metastatic Prostate Cancer

Who this might be right for
Metastatic Prostate CancerProstatic NeoplasmsProstate Cancer+2 more
National Cancer Institute (NCI) 96
Testing effectiveness (Phase 2)Study completedNCT01120236
What this trial is testing

Bicalutamide and Goserelin or Leuprolide Acetate With or Without Cixutumumab in Treating Patients With Newly Diagnosed Metastatic Prostate Cancer

Who this might be right for
Prostate AdenocarcinomaRecurrent Prostate CarcinomaStage IV Prostate Cancer
National Cancer Institute (NCI) 211
Early research (Phase 1)Ended earlyNCT04033328
What this trial is testing

Study of ORIC-101 in Combination With Enzalutamide

Who this might be right for
Prostatic Neoplasms
ORIC Pharmaceuticals 41
Testing effectiveness (Phase 2)Not Yet RecruitingNCT05896371
What this trial is testing

Personalized PSMA Radiopharmaceutical Therapy

Who this might be right for
CancerProstate CancerMetastatic Cancer+1 more
CHU de Quebec-Universite Laval 500
Testing effectiveness (Phase 2)Looking for participantsNCT05691465
What this trial is testing

Testing the Safety and Effectiveness of Radiation-based Treatment (Lutetium Lu 177 Dotatate) for Metastatic Prostate Cancer That Has Neuroendocrine Cells

Who this might be right for
Metastatic Prostate Adenocarcinoma With Neuroendocrine DifferentiationMetastatic Prostate Neuroendocrine CarcinomaMetastatic Prostate Small Cell Neuroendocrine Carcinoma+1 more
National Cancer Institute (NCI)
Testing effectiveness (Phase 2)Study completedNCT03939689
What this trial is testing

I-131-1095 Radioligand Plus Enzalutamide vs Enzalutamide for mCRPC That Progressed During Abiraterone (ARROW).

Who this might be right for
Metastatic Prostate CancerCastration-resistant Prostate CancerProstatic Neoplasm+2 more
Progenics Pharmaceuticals, Inc. 120
Not applicableStudy completedNCT00733213
What this trial is testing

Depiction of Prostate Cancer Treatment Alternatives in Greece

Who this might be right for
Locally Advanced or Metastatic Prostate Cancer.
AstraZeneca 310
Testing effectiveness (Phase 2)Study completedNCT00106418
What this trial is testing

A Research Study for Patients With Prostate Cancer

Who this might be right for
Prostate CancerMetastases
Celgene 35
Post-approval studies (Phase 4)Looking for participantsNCT06706921
What this trial is testing

18F-Fluciclovine PET/CT Impact on Predicting Clinical Outcome of 177Lu-PSMA-617 Therapy in Patients With Prostate Cancer

Who this might be right for
Prostatic NeoplasmsProstatic Neoplasms, Castration-ResistantMetastatic Prostate Cancer+8 more
VA Greater Los Angeles Healthcare System 15
Testing effectiveness (Phase 2)Study completedNCT00728663
What this trial is testing

Docetaxel and Cetuximab in Treating Patients With Metastatic Prostate Cancer

Who this might be right for
Prostate Cancer
Swiss Cancer Institute 35
Large-scale testing (Phase 3)UnknownNCT00363285
What this trial is testing

Cyproterone Acetate in Treating Patients With Newly Diagnosed Stage III or Stage IV Prostate Cancer

Who this might be right for
Prostate Cancer
St. Bartholomew's Hospital 900
Testing effectiveness (Phase 2)Looking for participantsNCT06689163
What this trial is testing

The Treatment of Metastatic Prostate Cancer With HRS-1167 Tablets Combined With Abiraterone Acetate Tablets and Prednisone

Who this might be right for
Prostate Cancer
Jiangsu HengRui Medicine Co., Ltd. 66
Testing effectiveness (Phase 2)Active Not RecruitingNCT03246347
What this trial is testing

A Trial of Androgen Deprivation, Docetaxel, and Enzalutamide for Metastatic Prostate Cancer

Who this might be right for
Prostate CancerProstate Adenocarcinoma
Wake Forest University Health Sciences 40
Not applicableLooking for participantsNCT02971358
What this trial is testing

Safety and Early Efficacy of Radical Prostatectomy for Newly Diagnosed Very High Risk Locally Advanced and Oligometastatic Prostate Cancer

Who this might be right for
Locally Advanced and Metastatic Prostate Cancer
Medical University of Vienna 200
Large-scale testing (Phase 3)Active Not RecruitingNCT00268476
What this trial is testing

Systemic Therapy in Advancing or Metastatic Prostate Cancer: Evaluation of Drug Efficacy

Who this might be right for
Prostate Cancer
Medical Research Council 11,992
Next Page
35